Drugs / Vigadexa
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT03580473 Comparator | Feb 2020 → Nov 2021 | cataract, uveitis | EMS | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Vigadexa | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03580473 ↗ |
| Route | Other | “opthalmic solution” NCT03580473 ↗ |